• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

FDA delays decision on Moderna's RSV shot until the end of May

cafead

Administrator
Staff member
  • cafead   May 10, 2024 at 12:02: PM
via What difference does a few weeks make?

Moderna will have to consider that after receiving word that the FDA will not meet a May 12 decision date for its respiratory syncytial virus (RSV) vaccine candidate. The vaccine maker said Friday that it was recently notified by the agency that, due to “administrative constraints,” a decision on mRNA-1345 has been pushed until the end of the month.

article source
 

<